|Product Description:||CDCAP® Respiratory Pathogen Panel is specifically designed to detect over 200 DNA- and RNA- respiratory pathogens, including 181 bacteria, 52 fungi, and 39 viruses, for obtaining near-complete sequence on Illumina platforms. This panel is aimed to detect respiratory pathogens in a single assay simultaneously, based on hybridization technology. It provides a fast, set-up workflow from library preparation to target enrichment, improving the sensitivity and coverage of detecting genomes. CDCAP® Respiratory Virus Panel provides access to analyze hundreds of respiratory pathogens and antimicrobial resistance (AMR) genes from whole genome sequence information.
CDCAP® Respiratory Pathogen Panel provides all required reagents needed, including NGS cDNA Iibrary preparation, target enrichment.
|Features:||Detecting over 200 respiratory pathogens, including viruses, bacteria, and fungi, and predicting associated antimicrobial resistance (AMR) markers. Excellent full genome coverage (>99% at 10X coverage). Short hands-on time from NGS library preparation to target enrichment (within 24h). Highly sensitive and accurate detection, reducing sequencing cost. Allowing targeting variants and viral mutations (SNV, Indel). Detecting respiratory pathogens relevant to coinfection detection.|
|Sample Input Size :||10-100 ng|
|Species:||Respiratory Bacteria and Virus|
|Sample Type:||Upper respiratory tract (URT), Nasopharyngeal samples (NP), Oropharyngeal samples (OP), Throat swabs, and others|
|Application:||Suitable for near-complete sequencing, identification and mutation analysis of over 200 respiratory pathogens. Predict drug resistance.|
|Storage:||-5 to -30°C|